Vascular Graft Solutions For Profit

Advancing Coronary Bypass Surgery with State-of-the-Art Technologies
Technology:
Therapeutic programs
Headquarters:
Tel Aviv-yafo, Tel Aviv, Israel
Funding Status:
Early Stage Venture
Investment Stage:
N/A
Founded Date:
2009
Number Of Exists:
N/A
Employee Number:
11-50
Industry:
Biomarkers of Longevity
Investor Type:
Company